Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey
Issued Date
2025-01-01
Resource Type
ISSN
15989100
eISSN
22881956
Scopus ID
2-s2.0-105005984017
Journal Title
Intestinal Research
Volume
23
Issue
2
Start Page
117
End Page
128
Rights Holder(s)
SCOPUS
Bibliographic Citation
Intestinal Research Vol.23 No.2 (2025) , 117-128
Suggested Citation
Limsrivilai J., Lai A.Y.h., Li S.T.H., Abdullah M., Ali R.A.R., Aniwan S., Bui H.H., Chou J.W., Hilmi I.N., Lim W.C., Sollano J., Teo M.M.H., Wei S.C., Leung W.K. Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey. Intestinal Research Vol.23 No.2 (2025) , 117-128. 128. doi:10.5217/ir.2024.00085 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/110453
Title
Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey
Author's Affiliation
Siriraj Hospital
Sunway University
The University of Hong Kong Li Ka Shing Faculty of Medicine
National Taiwan University Hospital
University of Santo Tomas, Manila
Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo
China Medical University Hospital
Universiti Malaya
National Taiwan University
Faculty of Medicine, Chulalongkorn University
Tan Tock Seng Hospital
Ferring Pharmaceuticals
University Medical Center
Sunway University
The University of Hong Kong Li Ka Shing Faculty of Medicine
National Taiwan University Hospital
University of Santo Tomas, Manila
Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo
China Medical University Hospital
Universiti Malaya
National Taiwan University
Faculty of Medicine, Chulalongkorn University
Tan Tock Seng Hospital
Ferring Pharmaceuticals
University Medical Center
Corresponding Author(s)
Other Contributor(s)
Abstract
Clinical guidelines typically endorse conventional therapies such as 5-aminosalicylic acid (5-ASA) as the mainstay of ulcerative colitis management. However, the degree of adoption and application of guideline recommendations by physicians within Asia remains unclear. This study aims to understand the prescribing patterns of 5-ASA and implementation of current guideline recommendations across Asian clinical practice. A physician survey was conducted among inflammatory bowel disease specialists in 8 Asian territories to understand practices and preferences in ulcerative colitis management, focusing on the use of 5-ASA and concordance with guideline recommendations. Survey findings were validated by country experts in diverse healthcare settings. Subgroup analyses stratified data by income levels and treatment reimbursement status. Ninety-eight valid responses were received from inflammatory bowel disease specialists or gastroenterologists among 8 economic entities. Significant differences were found in clinical practices and treatment preferences for ulcerative colitis management among different income-level and government-subsidy groups. Survey results are summarized in 8 findings that illustrate trends in 5-ASA use and guideline implementation across Asian territories. This study emphasizes socioeconomic factors that impact the adoption of guideline recommendations in real-world practice. Our findings indicate an eclectic approach to guideline implementation across Asia, based on resource availability and feasibility of treatment goals.